Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Time-resolved limited proteolysis of mitogen-activated protein kinase-activated protein kinase-2 determined by LC/MS only.

Tao L, Kiefer SE, Xie D, Bryson JW, Hefta SA, Doyle ML.

J Am Soc Mass Spectrom. 2008 Jun;19(6):841-54. doi: 10.1016/j.jasms.2008.02.014. Epub 2008 Mar 18.

2.

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM.

Proteomics. 2005 Aug;5(13):3226-45.

3.

Biomarker discovery in biological fluids.

Gao J, Garulacan LA, Storm SM, Opiteck GJ, Dubaquie Y, Hefta SA, Dambach DM, Dongre AR.

Methods. 2005 Mar;35(3):291-302. Epub 2005 Jan 12.

PMID:
15722225
4.

In vitro biomarker discovery for atherosclerosis by proteomics.

Fach EM, Garulacan LA, Gao J, Xiao Q, Storm SM, Dubaquie YP, Hefta SA, Opiteck GJ.

Mol Cell Proteomics. 2004 Dec;3(12):1200-10. Epub 2004 Oct 20.

5.

Identification of in vitro protein biomarkers of idiosyncratic liver toxicity.

Gao J, Ann Garulacan L, Storm SM, Hefta SA, Opiteck GJ, Lin JH, Moulin F, Dambach DM.

Toxicol In Vitro. 2004 Aug;18(4):533-41.

PMID:
15130611
6.

Changes in the protein expression of yeast as a function of carbon source.

Gao J, Opiteck GJ, Friedrichs MS, Dongre AR, Hefta SA.

J Proteome Res. 2003 Nov-Dec;2(6):643-9.

PMID:
14692458
7.

A high-yield method to extract peptides from rat brain tissue.

Kline TR, Pang J, Hefta SA, Opiteck GJ, Kiefer SE, Scheffler JE.

Anal Biochem. 2003 Apr 15;315(2):183-8.

PMID:
12689828
8.

Biomarker discovery in urine by proteomics.

Pang JX, Ginanni N, Dongre AR, Hefta SA, Opitek GJ.

J Proteome Res. 2002 Mar-Apr;1(2):161-9.

PMID:
12643536
9.

Proteomics in the post-genome age.

Dongre AR, Opiteck G, Cosand WL, Hefta SA.

Biopolymers. 2001;60(3):206-11. Review.

PMID:
11774226
10.

Role of nonspecific cross-reacting antigen, a CD66 cluster antigen, in activation of human granulocytes.

Klein ML, McGhee SA, Baranian J, Stevens L, Hefta SA.

Infect Immun. 1996 Nov;64(11):4574-9.

11.
12.

Microscale immobilized protease reactor columns for peptide mapping by liquid chromatography/mass spectral analyses.

Davis MT, Lee TD, Ronk M, Hefta SA.

Anal Biochem. 1995 Jan 1;224(1):235-44.

PMID:
7710077
13.

Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae.

Pessolani MC, Smith DR, Rivoire B, McCormick J, Hefta SA, Cole ST, Brennan PJ.

J Exp Med. 1994 Jul 1;180(1):319-27.

14.

Chemical definition, cloning, and expression of the major protein of the leprosy bacillus.

Rivoire B, Pessolani MC, Bozic CM, Hunter SW, Hefta SA, Mehra V, Brennan PJ.

Infect Immun. 1994 Jun;62(6):2417-25.

15.

Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification.

Kasuya J, Paz IB, Maddux BA, Goldfine ID, Hefta SA, Fujita-Yamaguchi Y.

Biochemistry. 1993 Dec 14;32(49):13531-6.

PMID:
8257688
18.

Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin.

Enghild JJ, Salvesen G, Th√łgersen IB, Valnickova Z, Pizzo SV, Hefta SA.

J Biol Chem. 1993 Apr 25;268(12):8711-6.

19.

Characterization of the major membrane protein of virulent Mycobacterium tuberculosis.

Lee BY, Hefta SA, Brennan PJ.

Infect Immun. 1992 May;60(5):2066-74.

20.

Phosphofructokinase from Fasciola hepatica: sequence of the cAMP-dependent protein kinase phosphorylation site.

Mahrenholz AM, Hefta SA, Mansour TE.

Arch Biochem Biophys. 1991 Aug 1;288(2):463-7.

PMID:
1832841
21.

Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae.

Sauter SL, Rutherfurd SM, Wagener C, Shively JE, Hefta SA.

Infect Immun. 1991 Jul;59(7):2485-93.

22.
23.

The putative role of members of the CEA-gene family (CEA, NCA an BGP) as ligands for the bacterial colonization of different human epithelial tissues.

Leusch HG, Drzeniek Z, Hefta SA, Markos-Pusztai Z, Wagener C.

Zentralbl Bakteriol. 1991 Apr;275(1):118-22.

PMID:
1718301
24.

Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor.

Enghild JJ, Salvesen G, Hefta SA, Th√łgersen IB, Rutherfurd S, Pizzo SV.

J Biol Chem. 1991 Jan 15;266(2):747-51.

25.
27.

Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA).

Leusch HG, Hefta SA, Drzeniek Z, Hummel K, Markos-Pusztai Z, Wagener C.

FEBS Lett. 1990 Feb 26;261(2):405-9.

28.

Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen.

Hinoda Y, Neumaier M, Hefta SA, Drzeniek Z, Wagener C, Shively L, Hefta LJ, Shively JE, Paxton RJ.

Proc Natl Acad Sci U S A. 1988 Sep;85(18):6959-63. Erratum in: Proc Natl Acad Sci U S A 1989 Mar;86(5):1668.

29.
30.

Site-specific semisynthetic variant of human hemoglobin.

Hefta SA, Lyle SB, Busch MR, Harris DE, Matthew JB, Gurd FR.

Proc Natl Acad Sci U S A. 1988 Feb;85(3):709-13.

Supplemental Content

Loading ...
Support Center